Column Group L P - Net Worth and Insider Trading
Column Group L P Net Worth
The estimated net worth of Column Group L P is at least $284 Million dollars as of 2024-04-29. Column Group L P is the 10% Owner of Constellation Pharmaceuticals Inc and owns about 6,230,638 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $212 Million. Column Group L P is the 10% Owner of Immune Design Corp and owns about 6,642,942 shares of Immune Design Corp (IMDZ) stock worth over $39 Million. Column Group L P is also the Director, 10% Owner of NGM Biopharmaceuticals Inc and owns about 21,743,413 shares of NGM Biopharmaceuticals Inc (NGM) stock worth over $33 Million. Details can be seen in Column Group L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Column Group L P has not made any transactions after 2023-11-16 and currently still holds the listed stock(s).
Transaction Summary of Column Group L P
Column Group L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Column Group L P owns 4 companies in total, including NGM Biopharmaceuticals Inc (NGM) , Nurix Therapeutics Inc (NRIX) , and Constellation Pharmaceuticals Inc (CNST) among others .
Click here to see the complete history of Column Group L P’s form 4 insider trades.
Insider Ownership Summary of Column Group L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2023-11-16 | 10 percent owner |
| NRIX | Nurix Therapeutics Inc | 2021-05-07 | 10 percent owner |
| CNST | Constellation Pharmaceuticals Inc | 2021-02-17 | 10 percent owner |
| IMDZ | Immune Design Corp | 2019-04-02 | 10 percent owner |
Column Group L P Latest Holdings Summary
Column Group L P currently owns a total of 3 stocks. Among these stocks, Column Group L P owns 6,230,638 shares of Constellation Pharmaceuticals Inc (CNST) as of February 17, 2021, with a value of $212 Million and a weighting of 74.54%. Column Group L P owns 6,642,942 shares of Immune Design Corp (IMDZ) as of October 27, 2017, with a value of $39 Million and a weighting of 13.68%. Column Group L P also owns 21,743,413 shares of NGM Biopharmaceuticals Inc (NGM) as of November 16, 2023, with a value of $33 Million and a weighting of 11.79%.
Latest Holdings of Column Group L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNST | Constellation Pharmaceuticals Inc | 2021-02-17 | 6,230,638 | 33.99 | 211,779,386 |
| IMDZ | Immune Design Corp | 2017-10-27 | 6,642,942 | 5.85 | 38,861,211 |
| NGM | NGM Biopharmaceuticals Inc | 2023-11-16 | 21,743,413 | 1.54 | 33,484,856 |
Holding Weightings of Column Group L P
Column Group L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Column Group L P has made a total of 5 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in Constellation Pharmaceuticals Inc is the sale of 10,000 shares on February 17, 2021, which brought Column Group L P around $369,500.
According to the SEC Form 4 filings, Column Group L P has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the acquisition of 2,681,000 shares on October 27, 2017, which cost Column Group L P around $11 Million.
According to the SEC Form 4 filings, Column Group L P has made a total of 115 transactions in NGM Biopharmaceuticals Inc (NGM) over the past 5 years, including 115 buys and 0 sells. The most-recent trade in NGM Biopharmaceuticals Inc is the acquisition of 22,631 shares on November 16, 2023, which cost Column Group L P around $15,615.
Insider Trading History of Column Group L P
- 1
Column Group L P Trading Performance
GuruFocus tracks the stock performance after each of Column Group L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Column Group L P is 21.57%. GuruFocus also compares Column Group L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Column Group L P within 3 months outperforms 68 times out of 121 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Column Group L P's insider trading performs compared to the benchmark.
Performance of Column Group L P
Average Return
-4.37%
Outperforming Transactions
56%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.88 | 21.57 | 0.37 | -4.37 | 10.94 | -25.38 |
| Relative Return to S&P 500(%) | 7.08 | 15.49 | -8.8 | -24.07 | -9.28 | -36.15 |
Column Group L P Ownership Network
Ownership Network List of Column Group L P
Ownership Network Relation of Column Group L P
Column Group L P Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
Column Group L P is the 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , Chief Financial Officer Jean-frederic Viret , and Principal Accounting Officer Irene Perlich .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, Column Group L P made 27 insider transaction in NGM Biopharmaceuticals Inc (NGM) with a net purchase of 2,247,495. Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 753,345 shares made by David V Goeddel , a net sale of 85,082 shares made by Jin-long Chen ,
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,082 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 3,000,840 shares were bought by its insiders, resulting in a net purchase of 2,915,758 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
Column Group L P Mailing Address
Above is the net worth, insider trading, and ownership report for Column Group L P. You might contact Column Group L P via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
